Direxion Daily S&P Biotech Bull 3X ETF
LABU
33 hedge funds and large institutions have $37.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 11 closing their positions.
76% more call options, than puts
Call options by funds: $68.8M | Put options by funds: $39.2M
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
60% more capital invested
Capital invested by funds: $23.3M → $37.4M (+$14.1M)
2.21% more ownership
Funds ownership: 4.19% → 6.4% (+2.2%)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
3% less funds holding
Funds holding: 34 → 33 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$14.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.66M |
| 3 |
Squarepoint
New York
|
+$2.13M |
| 4 |
Renaissance Technologies
New York
|
+$1.37M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$365K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$3.88M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.49M |
| 3 |
GS
GTS Securities
New York
|
-$1.46M |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$431K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$398K |
LABU Hedge Fund Activity: Q2 2025 in Review
33 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q2 2025, worth a combined $37.4M — up 60% from $23.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LABU positions and 11 closed out — a net gain of 1 holder — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Tidal Investments, opening a new position worth an estimated $14.6M. The largest seller was Jane Street, exiting entirely with an estimated $3.88M sold.
- 33 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q2 2025, down from 34 in Q1 2025.
- Funds reported $37.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q2 2025, up 60% quarter-over-quarter.
- 12 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q2 2025 and 11 closed out, a net change of +1 holder.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q2 2025 was Tidal Investments, an estimated $14.6M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q2 2025 was Jane Street, an estimated $3.88M sold.
Based on aggregated 13F filings for Q2 2025.